Additionally, patients who have CLL cell with high MMP-9 have been found to have more aggressive disease progression and less favorable clinical outcomes compared to patients who have CLL cells with low-to-negligible MMP-9 [4]. Here, MMP9 is linked to B-cell chronic lymphocytic leukemia.